<DOC>
	<DOCNO>NCT00125320</DOCNO>
	<brief_summary>The purpose study demonstrate safety efficacy RSD1235 compare placebo conversion atrial arrhythmia sinus rhythm subject follow valvular and/or coronary artery bypass graft surgery .</brief_summary>
	<brief_title>Response RSD1235 Compared Placebo Subjects With Atrial Arrhythmia After Heart Surgery</brief_title>
	<detailed_description>This multi-national , multi-center study double blind , randomize , placebo-controlled trial 2 parallel treatment arm ( 1 active , 1 placebo ) ass conversion efficacy safety 2 intravenous dos RSD1235 subject atrial fibrillation atrial flutter follow valvular and/or coronary artery bypass graft ( CABG ) surgery .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<criteria>Documented atrial arrhythmia valvular and/or coronary artery bypass graft surgery Unstable Class IV heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Treatment</keyword>
</DOC>